Medical device/wireless communications EMI
This article was originally published in The Gray Sheet
Executive SummaryHouse Government Operations/Information, Justice, Transportation and Agriculture Subcommittee, chaired by Rep. Gary Condit (D-Calif.), is considering holding a hearing addressing wireless communication device interference with electric medical devices before the current session of Congress adjourns, FDAers say. The subcommittee, which has oversight jurisdiction over the Federal Communications Commission, plans to ask FCC and FDA officials to testify at the hearing. Rep. Condit recently requested a General Accounting Office audit regarding the EMI issue that would evaluate the scope of the problem and look into such issues as "whether government agencies are adequately monitoring and responding to the situation" ("The Gray Sheet" Aug. 1, p. 1)
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.